DJIA 18,148.07 106.53 0.59%
NASDAQ 5,075.81 43.05 0.86%
S&P 500 2,117.53 13.33 0.63%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.75 0.78 (1.31%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $59.75 1.31%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.09
Previous Close $58.97
Daily Range $58.87 - $59.78
52-Week Range $52.49 - $63.62
Market Cap $168.8B
P/E Ratio 15.40
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,633,681
Average Daily Volume 10,639,501
Current FY EPS $3.43




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

5 Reasons Your Health Insurance Premium Will Likely Rise in 2016

If you don't want to pay more for health insurance, look away now! Here are five reasons why you should be prepared to pay more per month for your health insurance plan in 2016.

Abbvie Inc. Dividend Stock Analysis

Merck's (MRK) Keytruda a Step Closer to European Approval - Analyst Blog

Merck's (MRK) Keytruda a Step Closer to European Approval - Analyst Blog

10% Upside If J&J Is Even Partially Successful In Its R&D Plan

Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck

Uh-Oh! Billionaire George Soros Just Stepped on Another Biotech Landmine

George Soros is one of the most closely watched figures in the investing world. Retail investors, though, shouldn't necessarily take cues from his hedge fund. Here's why.

The 4 Stocks That Sank the DJIA on Friday

Expert Explains How To Play Merck In 2 Charts

IVV, JNJ, MRK, KO: ETF Outflow Alert

See More MRK News...

MRK's Top Competitors

MRK $59.75 (1.31%)
Current stock: MRK
JNJ $101.25 (0.43%)
Current stock: JNJ
NVS $103.61 (1.77%)
Current stock: NVS
RHHBY $37.03 (2.18%)
Current stock: RHHBY